SATURDAY, OCTOBER 1, 2016

ACIP recommends nasal spray flu vaccine for children

The Advisory Committee on Immunization Practices (ACIP) voted on Wednesday to recommend the preferential use of the nasal spray flu vaccine over the flu shot in healthy children between the ages of two and eight, when readily available.

The recommendation was made by a panel of experts in immunization and advisors to the Centers for Disease Control and Prevention.

The ACIP reviewed studies on the nasal spray vaccine's effectiveness in the age group. The shot is recommended when the spray is not available.

Children over the age of eight and adults are recommended to use the flu shot vaccine. The vaccine should be administered to everyone ages six months and older, on a yearly basis, according to recommendations by the ACIP and CDC.

The nasal spray recommendation has yet to be approved by the CDC director. After its approval, it will become official CDC policy and will be incorporated into the 2014-2015 influenza prevention and control recommendations, and published in a Morbidity and Mortality Weekly Report.

There are 15 experts on the ACIP who vote on recommendations. The members are selected by the U.S. Department of Health and Human Services following an application, interview and nomination process.